Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Spectrum Pharma Names SVP, CSO
Dr Tidmarsh is expected to provide the strategic planning and leadership necessary for managing all of Spectrum’s scientific operations, including clinical research, medical and regulatory affairs, biostatistics and
Dr Tidmarsh is expected to provide the strategic planning and leadership necessary for managing all of Spectrum’s scientific operations, including clinical research, medical and regulatory affairs, biostatistics and
Novasep and instrAction said that the contract will offer a combination of instrAction’s proprietary API-selective stationary phases (Instruction Receptor Phase) and Novasep purification capabilities and high performance chromatography
The transaction is valued at EUR1.7m including cash and stock, plus earn-out consideration of cash and stock with a value of up to EUR1.5m. Kai Lindevall, executive officer
Lorus claimed that the drug has shown selective and potent antitumor activity in preclinical investigations with a variety of human cancers, including colon cancer and non-small cell lung
The current study was initiated to evaluate the safety and efficacy of TJSL Capsules among 440 patients with primary dysmenorrheal. TJSL Capsules is a novel investigational drug to
The current milestones are related to the successful progression of the program to Phase 2 studies, which explore the use of the Amira discovered FLAP inhibitor in patients
Mr Jackson is expected to take up the responsibility for oversight of the company’s cGMP-certified therapeutic protein manufacturing facility in San Diego. Most recently, Mr Jackson was the
Cellectis Bioresearch said that the new method, based on meganuclease-driven targeted integration, for the generation of stable cell lines, is compatible with HTS. Cellectis said that the development
Amira’s entirely new Neuro option contains a comprehensive set of tools for neuroscience research, specifically MR diffusion tensor imaging (DTI) as well as CT and MR brain perfusion
Good Health is voluntarily recalling the product as it is being informed by the FDA that a lab analyses found that the product tested from certain batches of